The latest oncology treatment & supportive care news
Breast cancer resistance to tamoxifen elucidated
Researchers have discovered that a protein found naturally in cells that provides some protection from…
Browsing: Treatment and Support
CEO of Australian Prostate Cancer Research Clinches Global Oncology Prize
CEO of Australian Prostate Cancer Research (APCR), Mark Harrison, Melbourne, has clinched a global AUD $32,840 oncology grant for his role in…
Psychological intervention tackles fear of melanoma recurrence
A new psychological intervention has been shown to significantly reduce melanoma survivors’ fear of their…
ESMO 2016: Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer
A phase III trial of sunitinib has met its primary endpoint of disease-free survival for…
ESMO 2016: Single-arm trials for early access to cancer drugs
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer…
18th AGITG Annual Scientific Meeting – Looking Back, Moving Forward
This year marked the 25th anniversary of the Australasian Gastro-Intestinal Trials Group (AGITG) conducting and…
ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to…
Immune-boosting gut microbes can help chemotherapy drugs
Certain microbes in the gut can help improve the effectiveness of chemotherapy drugs, according to…
‘Game-changing’ immunotherapy doubles head and neck cancer survival
An immunotherapy drug has been hailed as a potential ‘game changer’ after being found to…
ESMO 2016: Significant survival gains from neoadjuvant chemo for high-risk soft tissue sarcoma
Neoadjuvant chemotherapy with an anthracycline plus ifosfamide was associated with significant survival gains in patients…